ClinicalTrials.Veeva

Menu

Deep Neuromuscular Block on Postoperative Delirium in Lumbar Surgery

K

Korea University

Status

Completed

Conditions

Lumbar Spine Disease

Treatments

Drug: Rocuronium for moderate NMB
Drug: Rocuronium for deep NMB

Study type

Interventional

Funder types

Other

Identifiers

NCT05453929
2021GR0301

Details and patient eligibility

About

The effect of deep neuromuscular blockade (NMB) during spine surgery reduced postoperative pain and bleeding in recent studies. Therefore by reducing these two factors, which were the contributing factors for postoperative delirium, deep NMB is expected to reduce the postoperative delirium. This study was designed to determine whether the deep NMB lowered the incidence of delirium after lumbar surgery.

Enrollment

230 patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 70 and more;
  • Scheduled for an elective lumbar spine surgery;
  • ASA physical status 1-3

Exclusion criteria

  • Diagnosed neuromuscular disorder;
  • Contraindications to the study drug, e. g. known allergy or hypersensitivity, hypotension, bradycardia, higher grade atrioventricular block;
  • Patient with pre-existing cognitive impairment or dementia

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

230 participants in 2 patient groups

Deep NMB
Experimental group
Description:
A TOF count of 0, and a PTC of 1 to 3 will be maintained, as close to 2 twitches as possible
Treatment:
Drug: Rocuronium for deep NMB
Moderate NMB
Active Comparator group
Description:
A TOF count of 1 to 3 will be maintained, as close to 2 twitches as possible
Treatment:
Drug: Rocuronium for moderate NMB

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems